Opexa Therapeutics to Present at the 6th Annual European Life Science CEO Forum

Published: Mar 04, 2013

Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelnaâ„¢, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the 6th Annual European Life Science CEO Forum on Tuesday, March 5, 2013, at 2:30 p.m. CET. The conference will be held at the Hilton Zurich Airport Hotel in Zurich, Switzerland.

Back to news